Serum trefoil factors in patients with inflammatory bowel disease

Digestion

Volumn 74, Issue 1, 2006, Pages 33-39

  Grønbæk, Henning ^a   Vestergaard, Else Marie ^a   Hey, Henrik ^b,c   Nielsen, Jens Nederby ^b   Nexø, Ebba ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b LILLEBAELT HOSPITAL   (Denmark)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

Crohn's disease; Inflammatory bowel diseases; Trefoil factors; Ulcerative colitis

Indexed keywords

ALBUMIN; AZATHIOPRINE; BUDESONIDE; C REACTIVE PROTEIN; MUCIN; OROSOMUCOID; PEPTIDE; PREDNISOLONE; TREFOIL FACTOR 1; TREFOIL FACTOR 2; TREFOIL FACTOR 3; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD LEVEL; CORTICOSTEROID THERAPY; CROHN DISEASE; DISEASE ACTIVITY; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG MEGADOSE; ENTERITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; ULCERATIVE COLITIS;

ADENOSINE TRIPHOSPHATASES; ADOLESCENT; ADULT; AGED; ANTI-INFLAMMATORY AGENTS; BIOLOGICAL MARKERS; COLITIS, ULCERATIVE; CROHN DISEASE; DNA-BINDING PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIDES; PREDNISOLONE; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 33751525342     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000096591     Document Type: Article

References (32)

1. Jakowlew SB, Breathnach R, Jeltsch JM, Masiakowski P, Chambon P: Sequence of the pS2 mRNA induced by estrogen in the human breast cancer cell line MCF-7. Nucleic Acids Res 1984;12:2861-2878.
2. Prud'homme JF, Fridlansky F, Le Cunff M, Atger M, Mercier-Bodart C, Pichon MF, Milgrom E: Cloning of a gene expressed in human breast cancer and regulated by estrogen in MCF-7 cells. DNA 1985;4:11-21.
3. Jørgensen KH, Thim L, Jacobsen HE: Pancreatic spasmolytic polypeptide (PSP). I. Preparation and initial chemical characterization of a new polypeptide from porcine pancreas. Regul Pept 1982;3:207-219.
4. Jørgensen KH, Thim L, Jacobsen HE: Preparation and characterization of PSP, a new polypeptide from porcine pancreas. Diabetologica 1981;21:288.
5. Thim L, Jorgensen KH, Jorgensen KD: Pancreatic spasmolytic polypeptide (PSP). II. Radioimmunological determination of PSP in porcine tissues, plasma and pancreatic juice. Regul Pept 1982;3:221-230.
6. Suemori S, Lynch-Devaney K, Podolsky DK: Identification and characterization of rat intestinal trefoil factor: tissue- and cell-specific member of the trefoil protein family. Proc Natl Acad Sci USA 1991;88:11017-11021.
7. Podolsky DK, Lynch-Devaney K, Stow JL, Oates P, Murgue B, deBeaumont M, et al: Identification of human intestinal trefoil factor. Goblet cell-specific expression of a peptide targeted for apical secretion. J Biol Chem 1993;268:6694-6702.
8. Rio MC, Bellocq JP, Daniel JY, Tomasetto C, Lathe R, Chenard MP, et al: Breast cancer-associated pS2 protein: synthesis and secretion by normal stomach mucosa. Science 1988;241:705-708.
9. Tomasetto C, Rio MC, Gautier C, Wolf C, Hareuveni M, Chambon P, Lathe R: hSP, the domain-duplicated homolog of pS2 protein, is co-expressed with pS2 in stomach but not in breast carcinoma. EMBO J 1990;9:407-414.
10. Podolsky DK, Lynch-Devaney K, Stow JL, Oates P, Murgue B, deBeaumont M, et al: Identification of human intestinal trefoil factor. Goblet cell-specific expression of a peptide targeted for apical secretion. J Biol Chem 1993;268:6694-6702.
11. Thim L: A new family of growth factor-like peptides. 'Trefoil' disulphide loop structures as a common feature in breast cancer associated peptide (pS2), pancreatic spasmolytic polypeptide (PSP), and frog skin peptides (spasmolysins). FEBS Lett 1989;250:85-90.
12. Thim L, Woldike HF, Nielsen PF, Christensen M, Lynch-Devaney K, Podolsky DK: Characterization of human and rat intestinal trefoil factor produced in yeast. Biochemistry 1995;34:4757-4764.
13. Jørgensen KH, Thim L, Jacobsen HE: Pancreatic spasmolytic polypeptide (PSP). I. Preparation and initial chemical characterization of a new polypeptide from porcine pancreas. Regul Pept 1982;3:207-219.
14. Babyatsky MW, deBeaumont M, Thim L, Podolsky DK: Oral trefoil peptides protect against ethanol-induced and indomethacin-induced gastric injury in rats. Gastroenterology 1996;110:489-497.
15. Cook GA, Thim L, Yeomans ND, Giraud AS: Oral human spasmolytic polypeptide protects against aspirin-induced gastric injury in rats. J Gastroenterol Hepatol 1998;13:363-370.
16. Playford RJ, Marchbank T, Chinery R, Evison R, Pignatelli M, Boulton RA, et al: Human spasmolytic polypeptide is a cytoprotective agent that stimulates cell migration. Gastroenterology 1995;108:108-116.
17. Poulsen SS, Thulesen J, Christensen L, Nexo E, Thim L: Metabolism of oral trefoil factor 2 (TFF2) and the effect of oral and parenteral TFF2 on gastric and duodenal ulcer healing in the rat. Gut 1999;45:516-522.
18. Tran CP, Cook GA, Yeomans ND, Thim L, Giraud AS: Trefoil peptide TFF2 (spasmolytic polypeptide) potently accelerates healing and reduces inflammation in a rat model of colitis. Gut 1999;44:636-642.
19. Farrell JJ, Taupin D, Koh TJ, Chen D, Zhao CM, Podolsky DK, Wang TC: TFF2/SP-deficient mice show decreased gastric proliferation, increased acid secretion, and increased susceptibility to NSAID injury. J Clin Invest 2002;109:193-204.
20. Mashimo H, Wu DC, Podolsky DK, Fishman MC: Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor. Science 1996;274:262-265.
21. Playford RJ, Marchbank T, Goodlad RA, Chinery RA, Poulsom R, Hanby AM: Transgenic mice that overexpress the human trefoil peptide pS2 have an increased resistance to intestinal damage. Proc Natl Acad Sci USA 1996;93:2137-2142.
22. Marchbank T, Cox HM, Goodlad RA, Giraud AS, Moss SF, Poulsom R, et al: Effect of ectopic expression of rat trefoil factor family 3 (intestinal trefoil factor) in the jejunum of transgenic mice. J Biol Chem 2001;276:24088-24096.
23. Thim L: Trefoil peptides: from structure to function. Cell Mol Life Sci 1997;53:888-903.
24. Wright NA, Poulsom R, Stamp G, Van Noorden S, Sarraf C, Elia G, et al: Trefoil peptide gene expression in gastrointestinal epithelial cells in inflammatory bowel disease. Gastroenterology 1993;104:12-20.
25. Baus-Loncar M, Kayademir T, Takaishi S, Wang T: Trefoil factor family 2 deficiency and immune response. Cell Mol Life Sci 2005;62:2947-2955.
26. Giraud AS, Pereira PM, Thim L, Parker LM, Judd LM: TFF2 inhibits iNOS/NO in monocytes, and nitrated protein in healing colon after colitis. Peptides 2004;25:803-809.
27. Vestergaard EM, Poulsen SS, Gronbaek H, Larsen R, Nielsen AM, Ejskjaer K, et al: Development and evaluation of an ELISA for human trefoil factor 3. Clin Chem 2002;48:1689-1695.
28. Vestergaard EM, Brynskov J, Ejskjaer K, Clausen JT, Thim L, Nexo E, Poulsen SS: Immunoassays of human trefoil factors 1 and 2: measured on serum from patients with inflammatory bowel disease. Scand J Clin Lab Invest 2004;64:146-156.
29. Mahmood A, Melley L, Fitzgerald AJ, Ghosh S, Playford RJ: Trial of trefoil factor 3 enemas, in combination with oral 5-aminosalicylic acid, for the treatment of mild-to-moderate left-sided ulcerative colitis. Aliment Pharmacol Ther 2005;21:1357-1364.
30. Gajhede M, Petersen TN, Henriksen A, Petersen JF, Dauter Z, Wilson KS, Thim L: Pancreatic spasmolytic polypeptide: first threedimensional structure of a member of the mammalian trefoil family of peptides. Structure 1993;1:253-262.
31. Thim L, Madsen F, Poulsen SS: Effect of trefoil factors on the viscoelastic properties of mucus gels. Eur J Clin Invest 2002;32:519-527.
32. Hoffmann W, Jagla W: Cell type specific expression of secretory TFF peptides: colocalization with mucins and synthesis in the brain. Int Rev Cytol 2002;213:147-181.